Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 14, 2018 - Issue 7
Submit an article Journal homepage
1,573
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Opportunities and obstacles in genotypic prediction of cytochrome P450 phenotypes

Joseph McGrawDepartment of Pharmaceutical and Administrative Sciences, Concordia University Wisconsin, Mequon, WI, USACorrespondence[email protected]
View further author information
,
Armin GerhardtMicrolitics LLC, Milwaukee, WI, USAView further author information
&
Tommy C. MorrisXavier University of Louisiana, Division of Basic Pharmaceutical Sciences, New Orleans, LA, USAView further author information
Pages 659-661 | Received 14 Feb 2018, Accepted 31 May 2018, Published online: 14 Jun 2018

References

  • Meyer UA. Pharmacogenetics - five decades of therapeutic lessons from genetic diversity. Nat Rev Genet. 2004;5(9):669–676. PubMed PMID: 15372089.
  • McGraw J. Chapter 16 - CYP450 and ethnicity A2. In: Padmanabhan, Sandosh, editor. Handbook of pharmacogenomics and stratified medicine. San Diego: Academic Press; 2014. p. 323–340.
  • de Leon J. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry. Expert Rev Mol Diagn. 2006;6(3):277–286. PubMed PMID: 16706732.
  • Saladores PH, Precht JC, Schroth W, et al. Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer. Expert Rev Mol Diagn. 2013;13(4):349–365. PubMed PMID: 23638818.
  • De Andrés F, Terán S, Hernández F, et al. To genotype or phenotype for personalized medicine? CYP450 drug metabolizing enzyme genotype–phenotype concordance and discordance in the Ecuadorian population. OMICS: J Integr Biol. 2016;20(12):699–710. .
  • Gao J, Tian X, Zhou J. et al. From genotype to phenotype: cytochrome P450 2D6-mediated drug clearance in humans. Mol Pharm. 2017; 14(3): 649–657. Epub 2017/ 02/18 PubMed PMID: 28211700.
  • Flockhart DA, Rae JM. Cytochrome P450 3A pharmacogenetics: the road that needs traveled. Pharmacogenomics J. 2003;3:3.
  • McGraw J, Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opin Drug Metab Toxicol. 2012;8(3):371–382. PubMed PMID: 22288606.
  • De S, Lopez-Bigas N, Teichmann SA. Patterns of evolutionary constraints on genes in humans. BMC Evol Biol. 2008;8:275. Epub 2008/10/09. PubMed PMID: 18840274; PubMed Central PMCID: PMCPMC2587479.
  • The Genomes Project C. A global reference for human genetic variation. Nature.2015;526:68. https://www.nature.com/articles/nature15393#supplementary-information
  • Kuehn BM. Study recruitment to accelerate precision medicine. JAMA. 2018;319(4):332.
  • Barter ZE, Tucker GT, Rowland-Yeo K. Response to “Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in Chinese population: opportunities and challenges”. Clin Pharmacokinet. 2014;53(2):203. Epub 2013/ 11/21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.